PharmaBlock Sciences Nanjing Inc Class A Strategic Asset Allocation Index
PharmaBlock Sciences Nanjing Inc Class A strategic asset allocation index. PharmaBlock Sciences Nanjing Inc Class A (300725) has a Strategic Asset Allocation Index of 62.4% as of June 2023. Strategic assets (PP&E of CN¥1.73 Billion plus long-term investments of CN¥-) total CN¥1.73 Billion, measured against net assets of CN¥2.77 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300725 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of PharmaBlock Sciences Nanjing Inc Class A (2016–2022)
Strategic asset allocation index of PharmaBlock Sciences Nanjing Inc Class A from 2016 to 2022. This chart shows how PharmaBlock Sciences Nanjing Inc Class A's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 62.4%, representing strategic assets of CN¥1.73 Billion against net assets of CN¥2.77 Billion CNY. Check PharmaBlock Sciences Nanjing Inc Class A tangible equity quality to evaluate the tangible quality of the company's equity base.
PharmaBlock Sciences Nanjing Inc Class A Strategic Asset Allocation Index by Year (2016–2022)
PharmaBlock Sciences Nanjing Inc Class A strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for PharmaBlock Sciences Nanjing Inc Class A from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of PharmaBlock Sciences Nanjing Inc Class A.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 62.5% | CN¥1.66 Billion | CN¥1.66 Billion | CN¥- | CN¥2.66 Billion | ▲ +17.9 pp |
| 2021 | 44.6% | CN¥1.17 Billion | CN¥1.17 Billion | CN¥- | CN¥2.63 Billion | ▲ +28.3 pp |
| 2020 | 16.3% | CN¥309.36 Million | CN¥309.36 Million | CN¥- | CN¥1.89 Billion | ▼ -18.5 pp |
| 2019 | 34.8% | CN¥257.69 Million | CN¥257.69 Million | CN¥- | CN¥740.87 Million | ▲ +13.8 pp |
| 2018 | 21.0% | CN¥125.88 Million | CN¥125.88 Million | CN¥- | CN¥599.73 Million | ▲ +2.5 pp |
| 2017 | 18.5% | CN¥93.04 Million | CN¥93.04 Million | CN¥- | CN¥503.59 Million | ▼ -11.0 pp |
| 2016 | 29.5% | CN¥74.98 Million | CN¥74.98 Million | CN¥- | CN¥254.15 Million | — |